Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a medication that activates GLP-1 receptors in the brain and pancreas, triggering multiple metabolic pathways that support weight loss and glucose control. Originally developed for type 2 diabetes management, clinical evidence now shows that semaglutide addresses a broader range of health concerns beyond blood sugar. Understanding what semaglutide can help with allows you to make an informed choice about whether this therapy aligns with your health goals.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Semaglutide Works for Weight Management and Metabolic Health
Semaglutide activates GLP-1 receptors, which regulate appetite signals in the hypothalamus and slow gastric emptying—the rate at which food leaves your stomach. This dual action reduces hunger intensity and prolongs feelings of fullness, leading to lower calorie intake without constant willpower battles. Clinical trials published in major journals demonstrated that patients on semaglutide lost 10-15% of body weight over 68 weeks, compared to 2-3% in placebo groups.
Beyond weight reduction, semaglutide improves insulin sensitivity and reduces fat storage in the liver and visceral organs. These metabolic shifts lower inflammation markers and decrease the mechanical strain on joints and the cardiovascular system. For individuals carrying excess weight, these improvements often translate into better energy levels, improved sleep quality, and reduced joint pain within the first few months of therapy.
Blood Sugar Control and Type 2 Diabetes Management
Semaglutide was originally developed to treat type 2 diabetes, and its glucose-lowering effects remain one of its most studied benefits. The medication stimulates the pancreas to release more insulin when blood sugar rises while simultaneously suppressing glucagon, a hormone that raises blood glucose. In clinical trials, HbA1c levels—a measure of average blood sugar over three months—decreased by 1.5-2.0 percentage points in patients using semaglutide.
The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Cardiovascular Protection and Heart Health Benefits
The SUSTAIN-6 trial, a landmark cardiovascular outcomes study, showed that semaglutide reduced the risk of major adverse cardiovascular events by 26% in patients with type 2 diabetes and existing heart disease. These benefits include lower rates of heart attack, stroke, and cardiovascular death, independent of weight loss alone. Semaglutide achieves this protection by reducing blood pressure, improving lipid profiles, and decreasing systemic inflammation—all key drivers of atherosclerotic disease.
Semaglutide's effects on heart health extend to individuals without diabetes who carry excess weight and elevated cardiovascular risk factors. The medication improves endothelial function (the health of blood vessel linings), reduces arterial stiffness, and lowers triglyceride levels. For people with metabolic syndrome—a cluster of conditions including high blood pressure, elevated cholesterol, and central obesity—semaglutide represents a powerful tool for reducing lifetime heart attack and stroke risk.
Personalized Semaglutide Therapy at PlexusDx: Tailored to Your Genetics
PlexusDx compounds semaglutide injections through licensed 503A compounding pharmacies, allowing precise dosing customization without the cost and wait times of brand-name medications. Starting at $149 per month with no insurance requirement, PlexusDx makes semaglutide therapy accessible across all 50 states. The medication is HSA and FSA eligible, further reducing out-of-pocket expenses for eligible patients.
The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
What specific health conditions does semaglutide help treat?
Semaglutide helps with weight management, type 2 diabetes, prediabetes, and cardiovascular disease risk reduction. It also improves metabolic markers including blood pressure, cholesterol, and inflammatory markers. PlexusDx offers compounded semaglutide injections for personalized therapy tailored to your health goals and genetic profile.
How much weight can I expect to lose with semaglutide?
No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Is compounded semaglutide from PlexusDx as effective as brand-name Ozempic?
PlexusDx compounds semaglutide through licensed 503A compounding pharmacies using the same active pharmaceutical ingredient as brand medications. The main differences are significantly lower cost (at $189/mo month-to-month, or from $149/mo on the 6-month plan vs. $900-$1,200/month) and custom dosing flexibility. Compounded medications are not FDA-approved, but the compound itself meets USP standards for purity and potency.
What are the common side effects of semaglutide?
Most common side effects include nausea, vomiting, diarrhea, and constipation, typically mild and temporary during dose escalation. Serious side effects are rare but include pancreatitis and gallbladder issues. PlexusDx provides personalized dosing strategies and medical support to minimize adjustment challenges and optimize tolerability.
How does the Precision Peptide Genetic Test improve my semaglutide outcomes?
No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
The Truth About Ozempic Pens: Does Ozempic Only Come in a Pen?
How to Lose Weight Faster on Wegovy: Strategies for Success